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10-day hyperlipidemic clamp in cats: effects on insulin
sensitivity, inflammation, and glucose metabolism-related genes
Abstract
Obesity and hyperlipidemia are associated with impaired insulin sensitivity in human type 2 diabetes
mellitus, possibly due to activation of a mild inflammatory response. Because obesity-induced insulin
resistance predisposes cats to diabetes and because hyperlipidemia is a frequent concurrent finding,
excess lipids may also impair insulin sensitivity in cats. Healthy cats (n=6) were infused with lipids
(Lipovenoes 10%) for 10 days to clamp blood triglycerides at the approximate concentration of
untreated feline diabetes (3-7 mmol/l). Controls received saline (n=5). On day 10, plasma adiponectin
and proinflammatory markers were measured. Whole-body insulin sensitivity was calculated following
an intravenous glucose tolerance test. Tissue mRNAs of glucose metabolism-related genes were
quantified in subcutaneous and visceral fat, liver, and skeletal muscles. Accumulation of lipids was
assessed in liver. At the termination of infusion, whole-body insulin sensitivity did not differ between
groups. Compared to saline, cats infused with lipids had 50% higher plasma adiponectin and 2-3 times
higher alpha(1)-acid glycoprotein and monocyte chemoattractant protein-1. Unexpectedly, lipid-infused
cats had increased glucose transporter-4 (GLUT4) mRNA in the visceral fat, and increased peroxisome
proliferative activated receptor-gamma2 (PPARgamma2) in subcutaneous fat; adiponectin expression
was not affected in any tissue. Lipid-infused cats developed hepatic steatosis. Although hyperlipidemia
induced systemic inflammation, whole-body insulin sensitivity was not impaired after 10 day infusion.
Increased circulating adiponectin may have contributed to prevent insulin resistance, possibly by
increasing GLUT4 and PPARgamma2 transcripts in fat depots.
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Abstract 22 
Obesity and hyperlipidemia are associated with impaired insulin sensitivity in human type 2 23 
diabetes mellitus, possibly due to activation of a mild inflammatory response. Because 24 
obesity-induced insulin resistance predisposes cats to diabetes and because hyperlipidemia is 25 
a frequent concurrent finding, excess lipids may also impair insulin sensitivity in cats. 26 
Healthy cats (n=6) were infused with lipids (LipovenoesR 10%) for 10 days to clamp blood 27 
triglycerides at the approximate concentration of untreated feline diabetes (3-7 mmol/l). 28 
Controls received saline (n=5). On day 10, plasma adiponectin and pro-inflammatory markers 29 
were measured. Whole-body insulin sensitivity was calculated following an intravenous 30 
glucose tolerance test. Tissue mRNAs of glucose metabolism-related genes were quantified in 31 
subcutaneous and visceral fat, liver and skeletal muscles. Accumulation of lipids was assessed 32 
in liver. 33 
At the termination of infusion, whole-body insulin sensitivity did not differ between groups. 34 
Compared to saline, cats infused with lipids had 50% higher plasma adiponectin and 2-3 35 
times higher α1-acid glycoprotein and monocyte chemoattractant protein-1. Unexpectedly, 36 
lipid-infused cats had increased glucose transporter-4 (GLUT4) mRNA in the visceral fat, and 37 
increased peroxisome proliferative activated receptor-γ2 (PPARγ2) in subcutaneous fat; 38 
adiponectin expression was not affected in any tissue. Lipid-infused cats developed hepatic 39 
steatosis. 40 
Although hyperlipidemia induced systemic inflammation, whole-body insulin sensitivity was 41 
not impaired after 10 day infusion. Increased circulating adiponectin may have contributed to 42 
preventing insulin resistance, possibly by increasing GLUT4 and PPARγ2 transcripts in fat 43 
depots. 44 
 45 
Keywords: feline, lipid-infusion, adiponectin, inflammation 46 
47 
 3 
Cats represent an interesting model to study mechanisms of type 2 diabetes [1-3]. In contrast 47 
to commonly used rodent models, cats spontaneously develop a form of diabetes that is 48 
clinically and pathologically similar to human type 2 diabetes. Among shared features, 49 
diabetic cats are often middle aged, genetics play a role in diabetes risk, obesity and physical 50 
inactivity are major predisposing factors, and impaired β-cell function is generally present in 51 
diabetic cats. The most striking histological similarity between human type 2 diabetes and 52 
feline diabetes is islet amyloidosis that is found in more than 80% of diabetic cats; the 53 
majority of diabetic cats have a β-cell loss of about 50%. Even though obese and diabetic cats 54 
are often hyperlipidemic, studies have not been performed to test whether cats may also serve 55 
as a model to study the pathogenesis of lipid-induced insulin resistance of human type 2 56 
diabetes. 57 
Circulating triglycerides and non-esterified fatty acids (NEFA) are commonly increased in 58 
obesity and in type 2 diabetic patients, and they are regarded as one of the major determinants 59 
in the pathogenesis of insulin resistance in both humans and rodent diabetic models [4]. 60 
However, precise mechanisms by which excess lipids may impair insulin action in peripheral 61 
tissues are incompletely understood. A greater release of cytokines and chemokines, and 62 
decreased synthesis of adiponectin from the expanded adipose tissue may contribute to this 63 
phenomenon [5-8]. Further, the induction of an inflammatory response may play a prominent 64 
role, since increased concentrations of lipids can also cause insulin resistance through direct 65 
activation of nuclear factor (NF)-kB pathways in peripheral insulin sensitive tissues [9-11]. In 66 
addition, obesity and type 2 diabetes in humans and rodent models are frequently 67 
accompanied by decreased expression of the glucose transporter-4 (GLUT4) and the 68 
peroxisome proliferative activated receptor-γ2 (PPARγ2) in fat depots or skeletal muscle 69 
[12,13]. Both gene products are crucial in maintaining insulin sensitivity, and hyperlipidemia 70 
may contribute to downregulation of their expression [14]. 71 
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The present study was therefore conducted to test whether sustained lipid infusion in cats 72 
causes whole-body insulin resistance and to test whether this is accompanied by activation of 73 
a systemic inflammatory response and by decreased circulating adiponectin. In addition, we 74 
tested whether hyperlipidemia induces an upregulation of genes frequently associated with 75 
insulin resistance (such as cytokines and chemokines), and a downregulation of genes that 76 
sustain insulin sensitivity (such as adiponectin, GLUT4 and PPARγ2) in peripheral insulin 77 
sensitive tissues [12]. 78 
To investigate the mechanisms through which excess lipids impair insulin sensitivity in vivo, 79 
infusion protocols should allow steady and long-term hyperlipidemia at a specific target 80 
concentration. This can be obtained by frequently adjusting the rate of lipid infusion. Our 81 
study was therefore performed in cats that were infused for 10 days with lipids to clamp 82 
plasma triglycerides at the approximate concentration found in untreated feline diabetes 83 
(triglycerides: 3-7 mmol/l) [15]. In the large majority of previous infusion studies in humans 84 
and rodents, lipids were typically administered for a limited period of time (i.e., few hours, up 85 
to 2 days) and at a constant infusion rate. A specific concentration of hyperlipidemia could 86 
not be maintained and often very high levels of triglycerides and NEFA were achieved 87 
[11,14,16-19]. 88 
89 
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Materials and Methods 89 
Cats 90 
Eleven neutered male, healthy domestic-shorthair cats (Charles River Laboratories, L'arbresle, 91 
France) were used following principles of laboratory animal care (Veterinary Office of 92 
Zürich, Switzerland, permission nr. 51/2007). Cats were 15-18 months old and were healthy 93 
based on physical examination and routine clinical laboratory data; cats were lean based on 94 
body condition score (i.e., score 5/9 in all cats; Body Condition Score chart, Nestlé-Purina, St. 95 
Louis, MO, USA). Cats had free access to water and were fed twice daily with a commercial 96 
cat diet (PVD Feline DM Diet, Nestlé-Purina); they were fed the same amount of diet per kg 97 
of body weight. 98 
The cats were randomly divided into 2 groups and infused over 10 days through a jugular 99 
catheter [20]. Six cats received a lipid emulsion (Lipovenoes 10%, Fresenius-Kabi, Bad 100 
Homburg, Germany). The emulsion consisted of triglycerides, including the following fatty 101 
acids: palmitic acid (C16:0) 9%, stearic acid (C18:0) 4%, oleic acid (C18:1, n-9) 26%, 102 
linoleic acid (C18:2, n-6) 54%, and linolenic acid (C18:3, n-3) 8%. Blood triglycerides were 103 
measured 2-3 times per day to target concentrations at 3-7 mmol/l. Similar total triglyceride 104 
concentrations are found in untreated diabetic cats [15]. Five cats served as controls and were 105 
infused with saline. Infusions were given to conscious cats. The site of the jugular catheter 106 
implantation was disinfected once daily and examined to identify gross signs of local 107 
inflammation (e.g., redness, oedema, purulent exudates). Rectal temperature was measured 108 
before each meal. 109 
 110 
Biochemical measurements 111 
Blood concentrations of glucose, triglycerides, NEFA and insulin were measured daily as 112 
described [20]. On day 10, total adiponectin was measured in plasma with a cross-reacting 113 
mouse ELISA (B-bridge International, Mountain View, CA, USA) [15]. The acute-phase 114 
 6 
protein of inflammation α1-acid glycoprotein (AGP) was measured using a feline-specific 115 
radial immunodiffusion test (Tridelta Development, Bray, Ireland); the monocyte 116 
chemoattractant protein-1 (MCP-1) was measured with a cross-reacting canine ELISA (R&D 117 
Systems, Oxon, UK) validated in our laboratory with cat plasma. The assay showed intra- and 118 
inter-assay coefficient of variation of 1.8-5.1% and 4.8-17.9%, respectively; the ratio of 119 
observed versus expected values at different dilutions was 0.8-1.0, and spiking recovery was 120 
69.1-80.5%. 121 
 122 
Assessment of insulin sensitivity 123 
During the 10-day infusion, blood samples were collected after overnight fasting through the 124 
jugular catheter daily at 08:00 hours to measure glucose and insulin in each cat. Values were 125 
used to calculate daily baseline insulin sensitivity with the homeostasis model assessment 126 
(HOMA) [21]. An intravenous glucose tolerance tests (IVGTT) was performed under 127 
anaesthesia in fasted cats 1 h after the end of the 10-day infusion. A glucose bolus of 1 g/kg 128 
(diluted with saline to a final concentration of 25%) was administered via the jugular catheter. 129 
Glucose and insulin were measured before the bolus and at 30, 60, 90 and 120 min thereafter. 130 
To estimate sensitivity to insulin, the whole-body insulin sensitivity index was calculated as 131 
described by Matsuda and DeFronzo [22]. 132 
 133 
Real-time PCR 134 
After the IVGTT, cats were euthanized with an intravenous overdose of barbiturate and tissue 135 
samples were collected within 30 minutes. Visceral fat was collected from near the jejunum, 136 
subcutaneous fat from the inguinal area, liver from the right caudal hepatic lobe and skeletal 137 
muscle from the musculus vastus lateralis. The samples were immediately frozen in liquid 138 
nitrogen and stored at -80 ºC. 139 
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Total RNA was extracted from all tissues and reverse-transcribed according to standard 140 
protocols [23]. cDNA was subjected to quantitative real-time PCR with feline-specific 141 
oligonucleotides suitable for SYBR-Green detection of adiponectin, glucose transporter-1 142 
(GLUT1), GLUT4, peroxisome proliferative activated receptor-γ1 (PPARγ1), PPARγ2, MCP-143 
1 as previously described [23]. Sets of primers and probes were also designed for the above 144 
targets and for interleukin (IL)-8 (Table 1). For the cytokines IL-1β, IL-6 and tumor necrosis 145 
factor (TNF)-α available oligonucleotide sequences were used [24]. All probes were labelled 146 
at the 5′-end with FAM (6-carboxyfluorescein) and at the 3′-end with TAMRA (5,6-147 
tetramethylrhodamine). PCR reactions consisted of 12.5 µl qPCR Mastermix (Eurogentec, 148 
Seraing, Belgium), primers and probe to final concentrations of 900 nM and 250 nM, 149 
respectively, and 5 µl of cDNA diluted 1:50 in a 25 µl total reaction volume. Cycling 150 
parameters were an initial denaturation of 10 min at 95 °C, followed by 45 cycles of 95 °C for 151 
15 s and 60 °C for 1 min. cDNA samples were run in triplicate and transcripts were quantified 152 
using the relative standard curve method. A template-free control and a sample without 153 
reverse transcriptase were included in each amplification run. Gene expression was 154 
normalized to the respective quantities of glyceraldehyde-3-phosphate dehydrogenase 155 
(GAPDH). PCR product identity was confirmed by DNA sequencing. 156 
 157 
Western blotting 158 
Visceral and subcutaneous adipose tissue samples were homogenized in lysis buffer (Santa 159 
Cruz Biotechnology, Santa Cruz, CA, USA). Homogenates were centrifuged at 15000 g for 160 
10 min (4 °C) and proteins were quantified in the supernatant. For immunoblotting, 70 µg of 161 
protein homogenate was diluted in sodium dodecyl sulfate (SDS) buffer and separated on a 162 
10% SDS–polyacrylamide gel. Proteins were transferred to nitrocellulose membranes and 163 
blocked with non-fat milk for 90 min at room temperature. Membranes were incubated 164 
overnight at 4 °C with a 1:750 dilution of a rabbit antimouse GLUT4 antiserum (GT41-S, 165 
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Alpha Diagnostic, Sant Antonio, TX, USA) cross-reacting with cats. After washing, blots 166 
were incubated with a horseradish peroxidase-conjugated donkey-anti-rabbit IgG (Santa 167 
Cruz) for 1 h at room temperature, followed by chemiluminescent detection. Western blotting 168 
was quantified by densitometry using β-actin as loading control. Peptide competition assay 169 
was performed with mouse GLUT4 blocking peptide (GT41-P, Alpha Diagnostic) to confirm 170 
specificity. 171 
 172 
Histopathology 173 
From the collected samples of visceral and subcutaneous fat and liver, one aliquot each was 174 
formalin-fixed for 24 h and paraffin-embedded. Paraffin sections were stained with hemalum. 175 
Adipocyte and hepatocyte cross-sectional size was measured with ImageJ software 176 
(http://rsb.info.nih.gov/ij/). Average cell size was measured on 5 pictures collected from each 177 
cat tissue at 40×-magnification; all adipocytes and hepatocytes were included in the analysis. 178 
From the aliquot of frozen liver, sections were stained with Oil red O using standard 179 
protocols. Lipid content of the liver was estimated by calculating the cross-sectional area 180 
occupied by lipid droplets on 3 pictures collected from each cat at 20×-magnification, using 181 
ImageJ. Tissue sections were analyzed in a blinded manner by two investigators (FG, EZ). 182 
 183 
Bacteremia 184 
To exclude that sustained infusion with the lipid emulsion led to bacteremia, which may 185 
contribute to inflammation, detection of bacteria was assessed in blood samples collected at 186 
day 10 in all cats with PCR amplification of the 16S rDNA using universal primers [25]. 187 
 188 
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Statistical analysis 189 
Data are shown as median and range. Data were analysed using GraphPad Prism 4.0 190 
(GraphPad, San Diego, CA, USA). Results in lipid- and saline-infused cats were compared 191 
using the Mann–Whitney test. Significance was set at p<0.05. 192 
193 
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Results 193 
Hyperlipidemic clamp, biochemical measurements and bacteremia 194 
Plasma triglyceride concentration was successfully targeted between 3-7 mmol/l throughout 195 
infusion (Fig. 1A); NEFA area under the curve during the infusion period was significantly 196 
higher in lipid-infused cats than in cats receiving saline (i.e., average increase of 1.7-fold) 197 
(Fig. 1B). Glucose and insulin concentrations did not differ between groups (Fig. 1C,D). Ten-198 
day lipid but not saline infusion increased body weight, on average by 10.7% [20]. 199 
On day 10, total adiponectin plasma concentration was approximately 2-fold higher in lipid-200 
infused than in saline-infused cats (Fig. 2A). Concentrations of the inflammatory proteins 201 
AGP and MCP-1 were 2- to 3-fold increased in lipid-infused cats (Fig. 2B,C). Based on 202 
amplification of the 16S rDNA, none of the cats infused with lipids or saline had bacteria in 203 
blood (not shown). All cats had normal rectal temperature throughout infusion, and did not 204 
develop sign of local inflammation at the implantation site of the jugular catheter. 205 
 206 
Insulin sensitivity 207 
Baseline insulin sensitivity calculated with HOMA was not different between lipid-infused 208 
cats and cats receiving saline during the infusion period (Fig. 3A). On day 10, whole-body 209 
insulin sensitivity calculated after the IVGTT was similar in the two groups (Fig. 3B). 210 
 211 
Real-time PCR and Western blotting 212 
mRNA levels of adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, the chemokines MCP-1 213 
and IL-8, and the cytokines IL-1β, IL-6 and TNF-α in peripheral insulin sensitive tissues are 214 
reported in table 2. Compared to controls, lipid-infused cats had increased transcript levels of 215 
GLUT4 and decreased GLUT1 in visceral and subcutaneous fat collected at the termination of 216 
infusion. Lipid-infused cats had higher expression of PPARγ2 in subcutaneous fat. The 217 
expression of adiponectin, PPARγ1, chemokines and cytokines was not different between 218 
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groups in any of the investigated tissue. GAPDH was used as a housekeeping gene and the 219 
CT levels were similar between lipid- and saline-infused cats (data not shown). 220 
In visceral fat, the protein content of GLUT4, as assessed by Western blotting, was higher in 221 
lipid-infused than saline-infused cats (Fig. 4A,B). The amount of GLUT4 protein was not 222 
significantly increased in the subcutaneous fat of lipid-infused cats (Fig. 4C). 223 
 224 
Histopathology 225 
At the termination of infusion, the average cross-sectional size of visceral and subcutaneous 226 
adipocytes did not differ between groups, whereas that of hepatocytes was almost 30% larger 227 
in lipid-infused than in saline-infused cats (Fig. 5A). With Oil red O staining, more than 50% 228 
of the cross-sectional area of the liver was occupied by large lipid droplets in lipid-infused 229 
cats, indicating the development of hepatic steatosis. In saline-infused cats lipid droplets 230 
occupied approximately 5% of the liver cross-sectional area and were comparably small (Fig. 231 
5B,C). 232 
233 
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Discussion 233 
In the present study we performed 10-day hyperlipidemic clamps in healthy cats to target 234 
triglycerides at concentrations found in feline diabetes; lipid infusion led to a 1.7 fold-increase 235 
of plasma total NEFA, similar to concentrations observed in untreated diabetic cats [15]. 236 
Interestingly, the sustained increase of triglycerides and total NEFA did not impair whole-237 
body insulin sensitivity, despite the activation of a systemic inflammatory response in cats. 238 
Circulating total adiponectin was increased, and the expression of GLUT4 and PPARγ2 239 
transcripts in visceral or subcutaneous fat was upregulated. 240 
Different from our results in cats, former studies in humans and rodents consistently showed 241 
an impairment of insulin sensitivity following lipid-infusion [10,11,17-19,26]. The 242 
composition of the lipid emulsion used in our study is similar to that used in most studies in 243 
humans and rodents [10,11,17-19,26], and contains more than 50% of all fatty acids as 244 
linoleic acid and less than 20% of saturated fatty acids (i.e., palmitic acid, C16:0; stearic acid, 245 
C18:0). Hence, it may be argued that the effect of hyperlipidemia on insulin sensitivity differs 246 
between cats and humans or rodents. It is however important to realize that, even though 247 
previously used emulsions were similar to ours, infusion times have been much shorter. 248 
Infusions in previous studies were usually carried out for 2-5 hours, and only in few cases up 249 
to a maximum of 2 days. Further, infusions were typically given at constant and relatively 250 
high rates. Experiments in humans and rodents have not been conducted to verify whether 251 
insulin sensitivity is still impaired after 10 days of lipid infusion in the diabetic range. It is 252 
therefore possible that rather than reflecting a species-specific difference in our cat study, 253 
lipid-induced insulin resistance that was observed during short-term lipid infusion in humans 254 
and rodents may no longer be present after 10 day infusion due to some as yet unknown 255 
compensatory mechanisms. 256 
At least in humans, insulin resistance seems to be associated with a particular fatty acid 257 
pattern. A comparison between the lipid fatty acid composition of serum in insulin resistant 258 
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patients with obesity or diabetes and healthy controls revealed a different fatty acid pattern 259 
common for both disorders; this is in particular represented by an increased proportion of 260 
palmitic acid and low concentrations of linoleic acid (C18:2, n-6) [27,28]. Similar findings 261 
were reported when insulin sensitivity was measured in a group of healthy subjects. 262 
Significant associations were seen between fatty acid concentrations in serum and insulin 263 
responsiveness [29], i.e. lower insulin sensitivity was observed in individuals with high 264 
palmitic acid and low linoleic acid concentrations. Because the lipid emulsion in our study 265 
was largely composed of triglycerides containing linoleic acid (54%) and only small amounts 266 
of palmitic acid (9%), it is conceivable that the specific fatty acid composition contributed to 267 
maintaining insulin sensitivity in cats in our study, despite the increase in body weight. 268 
Further, the lipid emulsion used for the experiment contained only a total of 13% saturated 269 
fatty acids (palmitic acid 9% and stearic acid 4%); thus, their proportion may have been 270 
insufficient to induce insulin resistance in cats because saturated fatty acids are mainly 271 
responsible to reduce insulin responsiveness in humans and rodents [30,31]. As mentioned, 272 
similar lipid emulsions with a high content of linoleic acid and having a low content of 273 
saturated fatty acids, rapidly decreased insulin sensitivity in humans and rodents, at least as a 274 
short-term effect [10,11,17-19,26]. Hence, we cannot rule-out that cats respond differently 275 
than other species to hyperlipidemia due to their particular metabolism of some of the infused 276 
fatty acids, or that high linoleic acid outweighed the potential detrimental effect of saturated 277 
fatty acids on insulin sensitivity. Further infusion experiments are warranted with individual 278 
NEFA to investigate the role of the cat as a suitable model to study the pathogenesis of lipid-279 
induced insulin resistance. 280 
Of note, despite similar caloric intake with diet in all animals, lipid-infused cats gained on 281 
average 11% of body weight during the infusion, possibly mainly in the form of body fat, and 282 
obesity per se is also expected to impair insulin responsiveness [1-3]. However, most studies 283 
in obese cats have been conducted with average increased body weight of above 40% [1-284 
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3,21]. It is thus possible that body weight did not increase to a degree high enough to cause 285 
insulin resistance in our cats. Here, an independent analysis of body weight, or body fat, on 286 
insulin sensitivity was not possible because body weight increased altogether with 287 
hyperlipidemia. 288 
A mild systemic and tissue inflammatory response usually accompanies insulin resistance in 289 
obese humans or rodents, and the enlarged fat mass in obese individuals has been shown to 290 
secrete increased amounts of cytokines, such as IL-1β, IL-6 and TNF-α, and chemokines, 291 
including IL-8 and MCP-1 [5-8]. Excess lipids may also directly contribute to inflammation 292 
by activating NF-kB pathways in peripheral insulin sensitive tissues [9-11]. In line with these 293 
findings, lipid infusion and associated increased body weight in cats triggered a systemic 294 
inflammatory response as indicated by increased concentrations of AGP, the most important 295 
feline acute-phase protein [32], and of MCP-1. However, cytokine and chemokine transcripts 296 
were not increased in insulin sensitive tissues. It has been shown that interleukins in human 297 
fat tissues are synthesized in increasing amounts mainly if adipocytes are hypertrophic [33], 298 
and hypertrophic adipocytes are associated with insulin resistance [34,35]. In our lipid-299 
infused cats, however, the adipocyte cross-sectional size in either visceral or subcutaneous fat 300 
was not augmented compared to controls; this may explain why the expression of cytokines 301 
and chemokines remained unaffected. Normal-sized adipocytes of lipid-infused cats may also 302 
have contributed to preserve insulin responsiveness. 303 
Lipid-infused cats showed clear signs of hepatic steatosis. The cross-sectional size of 304 
hepatocytes was increased by approximately 30% in lipid-infused cats. Based on Oil red O 305 
staining, hepatocytes accumulated large amounts of lipids. In humans with type 2 diabetes-306 
induced hepatic steatosis, higher expression levels of cytokines, in particular of IL-6, are 307 
observed in liver parenchyma [36]. However, patients with early stages of steatosis, having 308 
lipid-laden hepatocytes but no infiltrating inflammatory cells, show weak expression of 309 
cytokines in the liver [36]. Therefore, it is possible that in our lipid-infused cats, cytokine 310 
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expression would have been higher after an extended duration of lipid infusion. In addition, it 311 
has been shown that human hepatoma cells (HepG2) exposed to excess NEFA increase 312 
cytokine expression in the presence of palmitic acid but not with linoleic acid or oleic acid 313 
(C18:1) [36]. Similar to what was discussed above, the specific composition of the lipid 314 
emulsion with a low proportion of saturated fatty acids, may therefore have prevented 315 
measurable cytokine upregulation in cat liver. 316 
In lipid-infused cats circulating total adiponectin was 2-fold higher than in control cats. This 317 
finding was unexpected because previous studies reported lower adiponectin concentrations in 318 
obese humans and cats [37,38]. Low total adiponectin, particularly the isoform with high 319 
molecular weight which was not specifically measured in our study, is typically considered a 320 
strong and independent predictor of insulin resistance, at least in humans and rodents [37,39]. 321 
Thus, the fact that circulating adiponectin was not decreased in lipid-infused cats is in 322 
principle compatible with the unaltered whole-body insulin sensitivity in these animals. The 323 
source of increased total plasma adiponectin remains unknown since tissue expression at the 324 
mRNA level was not increased in any investigated tissue. A decreased clearance of 325 
adiponectin can therefore not be excluded. It is also possible that increased adiponectin was 326 
due to augmented body fat mass following adipocyte hyperplasia. 327 
Notably, elevated adiponectin levels have been suggested to play a direct role in the 328 
expression of several genes with a beneficial effect on insulin sensitivity. For instance, in vivo 329 
data with mice overexpressing adiponectin and in vitro data with pig adipocytes treated with 330 
adiponectin indicate an increased expression of the transcription factor PPARγ2 and a 331 
decreased expression of NF-kB; both factors may contribute to a downregulation of 332 
transcripts of cytokines, thus preventing insulin resistance [40,41]. Furthermore, rat 333 
adipocytes treated with adiponectin show improved glucose uptake, which may partly be due 334 
to AMP kinase activation; AMP kinase enhances cellular glucose transport due to increased 335 
GLUT4 transcription and translocation [42]. Hence, increased adiponectin may have 336 
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promoted the expression of PPARγ2 and GLUT4 in adipose tissues of lipid-infused cats in 337 
our study. Similarly, mRNA transcripts of PPARγ2 and GLUT4 were upregulated in visceral 338 
adipose tissue in lipid-infused rats [14]. In that study, the role of adiponectin was not 339 
specifically investigated. 340 
In conclusion, 10-day hyperlipidemic clamp resulted in increased serum concentrations of 341 
triglycerides and total NEFA similar to those seen in untreated feline diabetes. This was not 342 
associated with whole-body insulin resistance in cats, despite signs of systemic inflammation 343 
and a 10% increase in body weight. Increased circulating adiponectin may have helped to 344 
sustain insulin sensitivity at the level of control animals, possibly through increased GLUT4 345 
and PPARγ2 transcripts in fat depots. Further studies are needed to verify whether insulin 346 
sensitivity is differentially affected in adipose tissues, liver and skeletal muscles of cats 347 
rendered hyperlipidemic. Although feline diabetes and human type 2 diabetes share many 348 
common pathogenic mechanisms, including genetic predisposition, obesity-induced insulin 349 
resistance and islet amyloidosis [1-3], our study may suggest that lipid metabolism and its 350 
association to insulin resistance differs in cats. The infusion protocol used here specifically 351 
targeted total serum lipids at the concentrations observed in diabetic cats. We believe that this 352 
protocol allows to better mimic the naturally occurring disease than by infusing lipids at a 353 
constant rate (i.e., previous studies in humans and rodents); however, it is possible that the 354 
infusion period was not long enough to cause insulin resistance or that infusion of a different 355 
fatty acid emulsion may be necessary. 356 
357 
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Figure legends 481 
 482 
Fig. 1. (A) Plasma triglyceride concentrations during the 10-day infusion period in lipid- 483 
(black dot) and saline-infused (white dot) cats. Triglycerides were adequately targeted at 3-7 484 
mmol/l, in particular between day 3 and 10. Median values are reported. (B) Plasma NEFA 485 
concentrations were measured eight times (from day 2 to 9) during the infusion period in each 486 
lipid- (black dot) and saline-infused (white dot) cat. The calculated area under the curve for 487 
NEFA was higher in lipid- than in saline-infused (P<0.05) cats. (C) Glucose and (D) insulin 488 
concentrations during infusion in lipid- (black dot) and saline-infused (white dot) cats. 489 
Median values and interquartile ranges are shown. 490 
 491 
Fig. 2. Circulating concentration of adiponectin (A), α1-acid glycoprotein (B), and MCP-1 (C) 492 
were significantly higher in lipid-infused than saline-infused cats. Individual and median 493 
values are shown. 494 
 495 
Fig. 3. Baseline insulin sensitivity calculated with HOMA was not different between cats 496 
infused with lipids or saline from day 1 to day 10 (A). On day 10, insulin sensitivity 497 
calculated with the whole-body insulin sensitivity index was not different between groups 498 
(B). Individual and median values are shown. 499 
 500 
Fig. 4. Western blotting of GLUT4 in fat depots of cats. The protein content of GLUT4 was 501 
significantly higher in lipid-infused than saline-infused cats in visceral fat (A); representative 502 
Western blotting of two lipid-infused and two saline-infused cats (B). The protein content of 503 
GLUT4 was not different in subcutaneous fat (C). Individual and median values are shown. 504 
Results are normalized to β-actin. 505 
 506 
 24 
Fig. 5. Hepatocyte in cats. The average cross-sectional size of hepatocytes was significantly 507 
larger in lipid-infused than saline-infused cats. Individual and median values are shown. 508 
Values are expressed relative to one cat infused with saline (A). With Oil red O staining of 509 
approximately half of the cross-sectional area of the liver was occupied by large lipid droplets 510 
in hyperlipidemic cats (B). Small lipid droplets were observed in the liver of saline-infused 511 
cats (C). 512 
